Glorymar Ibáñez

510 total citations
10 papers, 304 citations indexed

About

Glorymar Ibáñez is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Glorymar Ibáñez has authored 10 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Organic Chemistry. Recurrent topics in Glorymar Ibáñez's work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (3 papers). Glorymar Ibáñez is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (3 papers). Glorymar Ibáñez collaborates with scholars based in United States, Venezuela and South Korea. Glorymar Ibáñez's co-authors include Minkui Luo, Gil Blum, Yaritzy M. Astudillo, Hakim Djaballah, Constantin Radu, David Shum, M.F. Amaya, Alena Siarheyeva, Peter J. Brown and Weihong Zheng and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Glorymar Ibáñez

10 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glorymar Ibáñez United States 8 281 20 15 14 11 10 304
Lynn DeLeeuw United States 10 269 1.0× 13 0.7× 44 2.9× 9 0.6× 17 1.5× 15 349
Yann‐Vaï Le Bihan United Kingdom 10 244 0.9× 44 2.2× 22 1.5× 12 0.9× 20 1.8× 17 281
Martin Karam Lebanon 7 190 0.7× 13 0.7× 19 1.3× 13 0.9× 3 0.3× 10 256
Michael T. Ouellette United States 5 124 0.4× 10 0.5× 35 2.3× 19 1.4× 18 1.6× 5 183
Katy Trent United States 4 521 1.9× 37 1.9× 50 3.3× 13 0.9× 13 1.2× 4 543
Brittany S. Morgan United States 8 358 1.3× 22 1.1× 19 1.3× 53 3.8× 29 2.6× 9 384
Kwang Hoe Kim South Korea 12 281 1.0× 49 2.5× 24 1.6× 19 1.4× 3 0.3× 23 350
Jessica Perrin Germany 3 124 0.4× 18 0.9× 25 1.7× 11 0.8× 28 2.5× 5 184
Zhonglei Chen United States 8 287 1.0× 36 1.8× 28 1.9× 15 1.1× 2 0.2× 10 330
Andrew Woodland United Kingdom 9 121 0.4× 69 3.5× 15 1.0× 11 0.8× 14 1.3× 14 236

Countries citing papers authored by Glorymar Ibáñez

Since Specialization
Citations

This map shows the geographic impact of Glorymar Ibáñez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glorymar Ibáñez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glorymar Ibáñez more than expected).

Fields of papers citing papers by Glorymar Ibáñez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glorymar Ibáñez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glorymar Ibáñez. The network helps show where Glorymar Ibáñez may publish in the future.

Co-authorship network of co-authors of Glorymar Ibáñez

This figure shows the co-authorship network connecting the top 25 collaborators of Glorymar Ibáñez. A scholar is included among the top collaborators of Glorymar Ibáñez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glorymar Ibáñez. Glorymar Ibáñez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ibáñez, Glorymar, Audrey Mauguen, Néstor Rosales, et al.. (2021). Translational Strategies for Repotrectinib in Neuroblastoma. Molecular Cancer Therapeutics. 20(11). 2189–2197. 8 indexed citations
2.
Ibáñez, Glorymar, Constantin Radu, Bhavneet Bhinder, et al.. (2017). Evaluation of Compound Optical Interference in High-Content Screening. SLAS DISCOVERY. 23(4). 321–329. 7 indexed citations
3.
Blum, Gil, Glorymar Ibáñez, Xiang‐Jun Rao, et al.. (2014). Small-Molecule Inhibitors of SETD8 with Cellular Activity. ACS Chemical Biology. 9(11). 2471–2478. 47 indexed citations
4.
Bhinder, Bhavneet, David Shum, Mu Li, et al.. (2014). Discovery of a Dicer-Independent, Cell-Type Dependent Alternate Targeting Sequence Generator: Implications in Gene Silencing & Pooled RNAi Screens. PLoS ONE. 9(7). e100676–e100676. 7 indexed citations
5.
Bhinder, Bhavneet, Christophe Antczak, David Shum, et al.. (2014). Chemical & RNAi Screening at MSKCC: A Collaborative Platform to Discover & Repurpose Drugs to Fight Disease. Combinatorial Chemistry & High Throughput Screening. 17(4). 298–318. 2 indexed citations
6.
Ibáñez, Glorymar, David Shum, Gil Blum, et al.. (2012). A High Throughput Scintillation Proximity Imaging Assay for Protein Methyltransferases. Combinatorial Chemistry & High Throughput Screening. 15(5). 359–371. 18 indexed citations
7.
Zheng, Weihong, Glorymar Ibáñez, Hong Wu, et al.. (2012). Sinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2. Journal of the American Chemical Society. 134(43). 18004–18014. 114 indexed citations
8.
Wang, Rui, Glorymar Ibáñez, Kabirul Islam, et al.. (2011). Formulating a fluorogenic assay to evaluate S -adenosyl- L -methionine analogues as protein methyltransferasecofactors. Molecular BioSystems. 7(11). 2970–2981. 40 indexed citations
9.
Ibáñez, Glorymar, et al.. (2010). An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases. Analytical Biochemistry. 401(2). 203–210. 60 indexed citations
10.
Compagnone, Reinaldo S., et al.. (2008). New Guanidine Alkaloids from the Leaves of Verbesina Peraffinis. Natural Product Communications. 3(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026